Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 1, 2006, Pages 83-89

  Hoogsteen, Ilse J ^a   Pop, Lucas A M ^a   Marres, Henri A M ^a   Merkx, Matthijs A W ^a   Van Den Hoogen, Franciscus J A ^a   Van Der Kogel, Albert J ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ARCON; Carbogen; Head and neck cancer; Hemoglobin levels; Nicotinamide; Squamous cell carcinoma

Indexed keywords

BIOLOGICAL ORGANS; CARCINOGENS; DISEASE CONTROL; HEMOGLOBIN; PATIENT TREATMENT; RADIOTHERAPY;

ARCON; CARBOGEN; HEAD AND NECK CANCER; HEMOGLOBIN LEVELS; NICOTINAMIDE; SQUAMOUS CELL CARCINOMA;

ONCOLOGY;

CARBOGEN; HEMOGLOBIN; NICOTINAMIDE; OXYGEN;

ADULT; AGED; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HEAD AND NECK CARCINOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NIACINAMIDE; OXYGEN; PROGNOSIS; RADIATION-SENSITIZING AGENTS; SEX FACTORS; TREATMENT OUTCOME;

EID: 29244472455     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.07.003     Document Type: Conference Paper

References (41)

1. M. Höckel, K. Schlenger, B. Aral Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 1996 4509 4515
2. D.M. Brizel, S.P. Scully, J.M. Harrelson Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 1996 941 943
3. D.M. Brizel, G.S. Sibley, L.R. Prosnitz Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
4. J.H.A.M. Kaanders, K.I.E.M. Wijffels, H.A.M. Marres Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
5. P. Vaupel, O. Thews, M. Höckel Treatment resistance of solid tumors Role of hypoxia and anemia Med Oncol 18 2001 243 259
6. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
7. M. Saunders, S. Dische Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide Br J Cancer 27 Suppl 1996 S271 S278
8. J.H.A.M. Kaanders, J. Bussink, A.J. van der Kogel ARCON A novel biology-based approach in radiotherapy Lancet Oncol 3 2002 728 737
9. J. Overgaard, H.S. Hansen, M. Overgaard A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 Radiother Oncol 46 1998 135 146
10. M. Henke, R. Laszig, C. Rübe Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy Randomized, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
11. G. Stüben, C. Pöttgen, K. Knühmann Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice Int J Radiat Oncol Biol Phys 55 2003 1358 1362
12. J. Bernier, J. Denekamp, A. Rojas ARCON: Accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas: The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC) Radiother Oncol 55 2000 111 119
13. J.H.A.M. Kaanders, L.A.M. Pop, H.A.M. Marres ARCON Experience in 215 patients with advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 52 2002 769 778
14. D.J. Chaplin, M.R. Horsman, M.J. Trotter The effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour J Natl Cancer Inst 82 1990 672 676
15. L. Martin, E. Lartigau, P. Weeger Changes in the oxygenation of head and neck tumors during carbogen breathing Radiother Oncol 27 1993 123 130
16. J. Dunst Low hemoglobin levels Influence on tumor biology and radiotherapy treatment outcome EJC Supplements 2 2004 3 10
17. S.J.-P. van Belle What is the value of hemoglobin as a prognostic and predictive factor in cancer? EJC Supplements 2 2004 11 19
18. K. Knight, S. Wade, L. Balducci Prevalence and outcomes of anemia in cancer A systematic review of the literature Am J Med 116 Suppl. 7A 2004 S11 S26
19. A. Becker, P. Stadler, R.S. Lavey Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466
20. P. Vaupel, A. Mayer, S. Briest Oxygenation gain factor A novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers Cancer Res 63 2003 7634 7637
21. International Union Against Cancer TNM classification of malignant tumours 6th ed. 1992 Wiley-Liss New York 19 51
22. J.H.A.M. Kaanders, R.W.M. van der Maazen A convenient and reliable method for carbogen breathing in man Radiother Oncol 29 1993 341 343
23. J.H.A.M. Kaanders, M.R.L. Stratford, J. Liefers Administration of nicotinamide during a five- to seven-week course of radiotherapy Pharmacokinetics, tolerance, and compliance Radiother Oncol 43 1997 67 73
24. A.A. Forastiere, H. Goepfert, M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
25. B. Dubray, V. Mosseri, F. Brunin Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer A prospective study Radiology 201 1996 553 558
26. P. Warde, B. O'Sullivan, R.G. Bristow T1/T2 glottic cancer managed by external beam radiotherapy The influence of pretreatment hemoglobin on local control Int J Radiat Oncol Biol Phys 41 1998 347 353
27. L.V. Johansen, C. Grau, J. Overgaard Laryngeal carcinoma Multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy Acta Oncol 42 2003 771 778
28. D.K. Kelleher, O. Thews, P. Vaupel Can erythropoietin improve tumor oxygenation? Strahlenther Onkol 174 Suppl. IV 1998 S20 S23
29. D.K. Kelleher, U. Matthiensen, O. Thews Tumor oxygenation in anemic rats Effects of erythropoietin treatment versus red blood cell transfusion Acta Oncol 34 1995 379 384
30. D.K. Kelleher, U. Matthiensen, O. Thews Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats Cancer Res 56 1996 4728 4734
31. J. Dunst, T. Kuhnt, H.G. Strauss Anemia in cervical cancers Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis Int J Radiat Oncol Biol Phys 56 2003 778 787
32. D.G. Hirst Anemia A problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12 1986 2009 2017
33. O. Thews, T. Wolloscheck, W. Dillenburg Microenvironmental adaptation of experimental tumours to chronic vs. acute hypoxia Br J Cancer 91 2004 1 9
34. D.M. Brizel, R.K. Dodge, R.W. Clough Oxygenation of head and neck cancer Changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 1999 113 117
35. M. Nordsmark, J. Overgaard Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer Acta Oncol 43 2004 396 403
36. M.I. Koukourakis, A. Giatromanolaki, V. Liberis Hypoxia inducible factor 1α and 2α expression is independent of anemia in patients with Stage I endometrial cancer Anticancer Res 22 2002 4137 4140
37. M.I. Koukourakis, A. Giatromanolaki, E. Sivridis Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer Int J Radiat Oncol Biol Phys 59 2004 67 71
38. D.A. Fein, W.R. Lee, A.L. Hanlon Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J Clin Oncol 13 1995 2077 2083
39. M. Grogan, G.M. Thomas, I. Melamed The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
40. M.J.J. van Acht, J. Hermans, D.E.S. Boks The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma Radiother Oncol 23 1992 229 235
41. A.W. Fyles, M. Milosevic, M. Pintilie Anemia, hypoxia, and transfusion in patients with cervix cancer A review Radiother Oncol 57 2000 13 19